Boosting NAD+ blunts toll-like receptor-4 induced type-I interferon in control and systemic lupus erythematosus monocytes

Reposted from the Journal of Clinical Investigation

 

Pilot clinical trial shows NR has anti-inflammatory effects in monocytes extracted from both ​​young, healthy subjects and patients diagnosed with systemic lupus erythematosus (SLE).

In The NewsANAD Staff